|
US FDA-University Partnership Could Speed Research-to-Trial Time
The U.S. Food and Drug Administration (FDA) and the University of Pennsylvania have signed a memorandum of understanding (MOU) to collaborate on research that will advance medical product development and the regulatory approval process.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives